Sorrento Therapeutics, Inc. (SRNE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 494.5 Million USD | -19.81% |
| 2021 | 616.68 Million USD | 56.09% |
| 2020 | 395.09 Million USD | -24.73% |
| 2019 | 524.87 Million USD | 12.34% |
| 2018 | 467.22 Million USD | 71.04% |
| 2017 | 273.16 Million USD | -13.3% |
| 2016 | 315.08 Million USD | 55.53% |
| 2015 | 202.58 Million USD | 517.1% |
| 2014 | 32.82 Million USD | 27.37% |
| 2013 | 25.77 Million USD | 4311.86% |
| 2012 | 584.17 Thousand USD | 62.57% |
| 2011 | 359.33 Thousand USD | -40.5% |
| 2010 | 603.95 Thousand USD | 71.06% |
| 2009 | 353.07 Thousand USD | 15040.22% |
| 2008 | 2332.00 USD | -29.01% |
| 2007 | 3285.00 USD | -99.3% |
| 2006 | 471.78 Thousand USD | 1351.65% |
| 2005 | 32.5 Thousand USD | -90.46% |
| 2004 | 340.53 Thousand USD | 0.22% |
| 2003 | 339.76 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 587.48 Million USD | 18.8% |
| 2023 Q2 | 654.64 Million USD | 11.43% |
| 2022 Q4 | 494.5 Million USD | 1.87% |
| 2022 Q1 | 629.43 Million USD | -9.4% |
| 2022 FY | 494.5 Million USD | -19.81% |
| 2022 Q3 | 485.4 Million USD | -2.21% |
| 2022 Q2 | 496.36 Million USD | -21.14% |
| 2021 Q4 | 694.76 Million USD | 11.8% |
| 2021 Q1 | 382.72 Million USD | -3.13% |
| 2021 Q2 | 593.38 Million USD | 55.04% |
| 2021 Q3 | 621.46 Million USD | 4.73% |
| 2021 FY | 616.68 Million USD | 56.09% |
| 2020 Q4 | 395.09 Million USD | -13.51% |
| 2020 Q3 | 456.8 Million USD | 0.87% |
| 2020 Q2 | 452.85 Million USD | -6.69% |
| 2020 Q1 | 485.32 Million USD | -7.53% |
| 2020 FY | 395.09 Million USD | -24.73% |
| 2019 FY | 524.87 Million USD | 12.34% |
| 2019 Q2 | 532.42 Million USD | 8.36% |
| 2019 Q4 | 524.87 Million USD | -5.29% |
| 2019 Q1 | 491.36 Million USD | 17.95% |
| 2019 Q3 | 554.2 Million USD | 4.09% |
| 2018 Q2 | 193.05 Million USD | -1.51% |
| 2018 Q4 | 416.58 Million USD | 14.32% |
| 2018 FY | 467.22 Million USD | 71.04% |
| 2018 Q1 | 196 Million USD | -12.89% |
| 2018 Q3 | 364.4 Million USD | 88.76% |
| 2017 FY | 273.16 Million USD | -13.3% |
| 2017 Q1 | 283.12 Million USD | -10.14% |
| 2017 Q2 | 288.57 Million USD | 1.92% |
| 2017 Q3 | 346.47 Million USD | 20.07% |
| 2017 Q4 | 225 Million USD | -35.06% |
| 2016 FY | 315.08 Million USD | 55.53% |
| 2016 Q1 | 184.81 Million USD | -8.77% |
| 2016 Q2 | 216.17 Million USD | 16.97% |
| 2016 Q3 | 206.56 Million USD | -4.45% |
| 2016 Q4 | 315.08 Million USD | 52.54% |
| 2015 FY | 202.58 Million USD | 517.1% |
| 2015 Q2 | 41.56 Million USD | 32.97% |
| 2015 Q1 | 31.25 Million USD | -4.79% |
| 2015 Q3 | 178.51 Million USD | 329.5% |
| 2015 Q4 | 202.58 Million USD | 13.48% |
| 2014 Q2 | 32.29 Million USD | 2.64% |
| 2014 Q3 | 33.13 Million USD | 2.61% |
| 2014 FY | 32.82 Million USD | 27.37% |
| 2014 Q4 | 32.82 Million USD | -0.94% |
| 2014 Q1 | 31.46 Million USD | 22.09% |
| 2013 Q4 | 25.77 Million USD | 262.8% |
| 2013 FY | 25.77 Million USD | 4311.86% |
| 2013 Q2 | 2.01 Million USD | 7.74% |
| 2013 Q1 | 1.87 Million USD | 220.81% |
| 2013 Q3 | 7.1 Million USD | 251.81% |
| 2012 Q2 | 415.67 Thousand USD | 29.9% |
| 2012 Q4 | 584.17 Thousand USD | 7.34% |
| 2012 Q3 | 544.24 Thousand USD | 30.93% |
| 2012 FY | 584.17 Thousand USD | 62.57% |
| 2012 Q1 | 319.99 Thousand USD | -10.95% |
| 2011 Q1 | 1.11 Million USD | 84.81% |
| 2011 Q4 | 359.33 Thousand USD | -23.87% |
| 2011 Q3 | 471.99 Thousand USD | 11.05% |
| 2011 Q2 | 425.02 Thousand USD | -61.92% |
| 2011 FY | 359.33 Thousand USD | -40.5% |
| 2010 Q3 | 423.5 Thousand USD | 83.27% |
| 2010 FY | 603.95 Thousand USD | 71.06% |
| 2010 Q2 | 231.07 Thousand USD | 25.13% |
| 2010 Q4 | 603.95 Thousand USD | 42.61% |
| 2010 Q1 | 184.66 Thousand USD | -47.7% |
| 2009 FY | 353.07 Thousand USD | 15040.22% |
| 2009 Q1 | 38.09 Thousand USD | 1533.7% |
| 2009 Q2 | 38 Thousand USD | -0.24% |
| 2009 Q3 | 215.63 Thousand USD | 467.34% |
| 2009 Q4 | 353.07 Thousand USD | 63.74% |
| 2008 Q1 | 11.7 Thousand USD | 256.29% |
| 2008 FY | 2332.00 USD | -29.01% |
| 2008 Q4 | 2332.00 USD | 1133.86% |
| 2008 Q3 | 189.00 USD | 0.0% |
| 2008 Q2 | - USD | -100.0% |
| 2007 Q1 | 36.58 Thousand USD | -92.25% |
| 2007 Q3 | 4000.00 USD | -75.76% |
| 2007 Q4 | 3285.00 USD | -17.88% |
| 2007 Q2 | 16.5 Thousand USD | -54.9% |
| 2007 FY | 3285.00 USD | -99.3% |
| 2006 FY | 471.78 Thousand USD | 1351.65% |
| 2006 Q2 | 32.5 Thousand USD | 0.0% |
| 2006 Q4 | 471.78 Thousand USD | 1351.65% |
| 2006 Q3 | 32.5 Thousand USD | 0.0% |
| 2006 Q1 | 32.5 Thousand USD | 0.0% |
| 2005 Q1 | 340.72 Thousand USD | 0.06% |
| 2005 Q4 | 32.5 Thousand USD | -90.47% |
| 2005 Q3 | 341.1 Thousand USD | 0.06% |
| 2005 Q2 | 340.91 Thousand USD | 0.06% |
| 2005 FY | 32.5 Thousand USD | -90.46% |
| 2004 Q1 | 339.95 Thousand USD | 0.0% |
| 2004 Q3 | 340.34 Thousand USD | 0.06% |
| 2004 FY | 340.53 Thousand USD | 0.22% |
| 2004 Q2 | 340.15 Thousand USD | 0.06% |
| 2004 Q4 | 340.53 Thousand USD | 0.06% |
| 2003 FY | 339.76 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -47.273% |
| Alkermes plc | 933.53 Million USD | 47.028% |
| Agenus Inc. | 462.29 Million USD | -6.968% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 87.791% |
| Aptorum Group Limited | 5.25 Million USD | -9307.146% |
| Ardelyx, Inc. | 130.76 Million USD | -278.172% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -3.369% |
| Bicycle Therapeutics plc | 224.41 Million USD | -120.358% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -279.778% |
| ChromaDex Corporation | 26.5 Million USD | -1765.509% |
| Chimerix, Inc. | 19.74 Million USD | -2404.477% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1305.769% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -581.452% |
| CRISPR Therapeutics AG | 346.76 Million USD | -42.605% |
| Precision BioSciences, Inc. | 140.92 Million USD | -250.915% |
| Dyadic International, Inc. | 2.34 Million USD | -21026.986% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2940.7% |
| Fortress Biotech, Inc. | 165.93 Million USD | -198.006% |
| Lantern Pharma Inc. | 2.73 Million USD | -17949.869% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -591.814% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -13913.815% |
| Incyte Corporation | 1.59 Billion USD | 68.943% |
| IO Biotech, Inc. | 17.55 Million USD | -2716.752% |
| Jaguar Health, Inc. | 45.86 Million USD | -978.16% |
| Novavax, Inc. | 2.57 Billion USD | 80.775% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1271.427% |
| Opthea Limited | 264.6 Million USD | -86.888% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -278.334% |
| ContextLogic Inc. | 206 Million USD | -140.053% |
| MiMedx Group, Inc. | 96.33 Million USD | -413.349% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -929.755% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -13913.172% |
| NextCure, Inc. | 14.99 Million USD | -3197.386% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -12134.265% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -7306.155% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -958.022% |
| Vaxcyte, Inc. | 167.44 Million USD | -195.319% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1386.837% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -110.238% |
| Pharming Group N.V. | 244.07 Million USD | -102.607% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -4047.869% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -286.967% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -7384.306% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -7384.306% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -499.892% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -7344.061% |
| Acelyrin, Inc. | 86.35 Million USD | -472.66% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -37961.376% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -3339.106% |
| Summit Therapeutics Inc. | 125.25 Million USD | -294.796% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -5116.89% |
| Senti Biosciences, Inc. | 52.57 Million USD | -840.65% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -619.003% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -226.383% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -25181.646% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -36926.23% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -118.007% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -5179.268% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -117.419% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -4430.96% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1697.496% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3985.265% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -1.625% |
| Immix Biopharma, Inc. | 3.72 Million USD | -13186.884% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1207.81% |
| MEI Pharma, Inc. | 8.35 Million USD | -5818.719% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1604.322% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -42.272% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -239.009% |
| Fortress Biotech, Inc. | 165.93 Million USD | -198.006% |
| Precigen, Inc. | 41.64 Million USD | -1087.468% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -890.405% |
| AlloVir, Inc. | 45.01 Million USD | -998.543% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -279.408% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -258.86% |
| ImmuCell Corporation | 18.81 Million USD | -2528.267% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1651.963% |
| Onconetix, Inc. | 23.18 Million USD | -2033.262% |
| PureTech Health plc | 125.58 Million USD | -293.771% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -5425.24% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1342.474% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -20125.317% |
| Seer, Inc. | 39.36 Million USD | -1156.215% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -699.736% |
| Innoviva, Inc. | 568.55 Million USD | 13.023% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1716.178% |
| ESSA Pharma Inc. | 3.49 Million USD | -14048.754% |
| GlycoMimetics, Inc. | 6.9 Million USD | -7064.644% |
| GT Biopharma, Inc. | 6.63 Million USD | -7355.284% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -87.038% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -81.613% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -488.519% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -4959.433% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1720.122% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -15229.938% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -570.366% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3028.081% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -4379.376% |
| Soligenix, Inc. | 7.27 Million USD | -6697.464% |
| Century Therapeutics, Inc. | 175.94 Million USD | -181.065% |
| Kura Oncology, Inc. | 51.66 Million USD | -857.201% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -307.735% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -11864.892% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -7376.865% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -95.769% |
| Autolus Therapeutics plc | 263.9 Million USD | -87.38% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -4617.697% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -456.497% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -954.413% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -40.145% |
| GRI Bio, Inc. | 2.69 Million USD | -18235.521% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -60981.789% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1490.521% |
| IGM Biosciences, Inc. | 220.17 Million USD | -124.596% |
| INmune Bio, Inc. | 18.86 Million USD | -2521.721% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -92.807% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1756.139% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -18091.138% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -14975.271% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -745.965% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -414.262% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -86.794% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 39.916% |
| Verastem, Inc. | 71.18 Million USD | -594.681% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -905.59% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1181.842% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -910.605% |
| Histogen Inc. | 5.69 Million USD | -8580.165% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -11175.73% |
| Surrozen, Inc. | 8.14 Million USD | -5971.32% |
| Organovo Holdings, Inc. | 2.74 Million USD | -17895.233% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -157458.195% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -779.441% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2894.846% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -867.671% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -59704.565% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -290.222% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -4473.033% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -227.73% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -18865.998% |
| Apollomics, Inc. | 14.15 Million USD | -3394.022% |
| Amarin Corporation plc | 279.58 Million USD | -76.871% |
| Mesoblast Limited | 188.79 Million USD | -161.925% |
| Turnstone Biologics Corp. | 14.14 Million USD | -3395.257% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -173.53% |
| Synaptogenix, Inc. | 5.52 Million USD | -8843.155% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -7338.463% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -190.703% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5678.869% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -28038.783% |
| Exelixis, Inc. | 678.44 Million USD | 27.111% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1974.109% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -201.445% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 16.779% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4530.146% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -30357.263% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1170.35% |
| Gritstone bio, Inc. | 125.91 Million USD | -292.72% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3269.508% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -9617.926% |
| Avid Bioservices, Inc. | 275.66 Million USD | -79.386% |
| Insmed Incorporated | 1.66 Billion USD | 70.242% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -6327.183% |
| MediWound Ltd. | 27.18 Million USD | -1718.917% |
| OmniAb, Inc. | 87.4 Million USD | -465.8% |
| Alector, Inc. | 487.66 Million USD | -1.403% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -22.568% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2583.902% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1188.69% |
| Zai Lab Limited | 240.17 Million USD | -105.894% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 21.514% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1591.959% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -420.114% |
| Immunic, Inc. | 25.36 Million USD | -1849.342% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -614.237% |
| Veracyte, Inc. | 93.71 Million USD | -427.651% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -18798.387% |
| FibroGen, Inc. | 585.72 Million USD | 15.574% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2744.785% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -75619.977% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -8643.925% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 93.541% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -5932.069% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -488.547% |
| TG Therapeutics, Inc. | 169.08 Million USD | -192.462% |
| Galecto, Inc. | 5.89 Million USD | -8287.195% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -5869.447% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 81.114% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1615.735% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3818.144% |
| XBiotech Inc. | 8.39 Million USD | -5789.115% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3269.508% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -829.878% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -36.189% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1739.417% |
| Theravance Biopharma, Inc. | 169 Million USD | -192.602% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 59.32% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 1.182% |
| Vaxxinity, Inc. | 30.94 Million USD | -1498.077% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 49.15% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -8099.307% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 33.644% |
| NexImmune, Inc. | 5.08 Million USD | -9626.326% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -133049.432% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -15982.388% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 93.042% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -9494.608% |
| Scopus BioPharma Inc. | 7.45 Million USD | -6533.756% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1780.691% |
| Ainos, Inc. | 7.39 Million USD | -6587.775% |
| Pluri Inc. | 34.11 Million USD | -1349.663% |
| Prothena Corporation plc | 135.01 Million USD | -266.257% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -103.415% |
| Celularity Inc. | 102.92 Million USD | -380.437% |
| Rallybio Corporation | 9.43 Million USD | -5140.663% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1922.945% |
| MeiraGTx Holdings plc | 319.99 Million USD | -54.538% |
| Omeros Corporation | 403.25 Million USD | -22.63% |
| Humacyte, Inc. | 114.67 Million USD | -331.219% |
| Immunocore Holdings plc | 228.15 Million USD | -116.74% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -10043.774% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -544.395% |
| Blueprint Medicines Corporation | 918.64 Million USD | 46.17% |
| CalciMedica, Inc. | 4.02 Million USD | -12176.787% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2733.538% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -220.812% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -476.237% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -78.013% |
| Pulmatrix, Inc. | 15.96 Million USD | -2997.845% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3035.161% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1909.709% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -97.166% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -873.711% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 59.153% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1455.892% |
| Nutriband Inc. | 1.07 Million USD | -45733.747% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -4550.701% |
| Vor Biopharma Inc. | 59.1 Million USD | -736.676% |
| Roivant Sciences Ltd. | 773.95 Million USD | 36.106% |
| Evogene Ltd. | 17.99 Million USD | -2648.799% |
| ProKidney Corp. | 29.21 Million USD | -1592.597% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -587.018% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -70044.812% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 73.82% |
| CorMedix Inc. | 11.91 Million USD | -4049.426% |
| BioLineRx Ltd. | 50.7 Million USD | -875.324% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -230.866% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -459.14% |
| Atai Life Sciences N.V. | 49.16 Million USD | -905.876% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1487.391% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2653.084% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -296.763% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -8646.18% |
| MediciNova, Inc. | 3.89 Million USD | -12607.241% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2605.339% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -32774.32% |
| GeoVax Labs, Inc. | 3.51 Million USD | -13949.026% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -24.48% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1511.303% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 81.831% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2998.039% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1484.914% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -742.664% |
| Absci Corporation | 58.3 Million USD | -748.156% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2496.12% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1442.352% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -570.157% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -465.263% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1364.344% |
| Allakos Inc. | 74.79 Million USD | -561.17% |
| Imunon, Inc. | 8.53 Million USD | -5697.002% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2097.72% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -330.712% |
| BioAtla, Inc. | 48.98 Million USD | -909.49% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4530.146% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -17694.494% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -278.632% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -3378.783% |
| XOMA Corporation | 145.58 Million USD | -239.682% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1368.911% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -619.192% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1465.05% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -699.879% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -999.764% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -921.671% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -17130.279% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -5961.632% |
| Akari Therapeutics, Plc | 4.58 Million USD | -10687.718% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2688.617% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 70.02% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -122331.098% |
| UroGen Pharma Ltd. | 243.52 Million USD | -103.065% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -54.011% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -17806.884% |
| Orgenesis Inc. | 35.53 Million USD | -1291.611% |
| Entera Bio Ltd. | 1.37 Million USD | -35759.971% |
| GH Research PLC | 6.7 Million USD | -7279.63% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -7172.191% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2526.734% |
| Xencor, Inc. | 283.55 Million USD | -74.394% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -16462.72% |
| Replimune Group, Inc. | 113.21 Million USD | -336.791% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -13061.899% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -377.648% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -122331.098% |
| Portage Biotech Inc. | 4.45 Million USD | -11012.562% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -32774.32% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2045.375% |
| OncoCyte Corporation | 49.29 Million USD | -903.102% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -11853.887% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -61908.642% |
| Purple Biotech Ltd. | 10 Million USD | -4842.619% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -8446.647% |
| scPharmaceuticals Inc. | 57.26 Million USD | -763.605% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3891.832% |
| HilleVax, Inc. | 78.9 Million USD | -526.683% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -9692.257% |
| Tharimmune, Inc. | 1.81 Million USD | -27144.984% |
| Genprex, Inc. | 3.25 Million USD | -15095.986% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1723.478% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -9344.404% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -239952.913% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -137819.888% |
| OKYO Pharma Limited | 7.42 Million USD | -6563.782% |
| Savara Inc. | 37.19 Million USD | -1229.611% |
| Curis, Inc. | 57.61 Million USD | -758.344% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1778.13% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1161.509% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -34145.776% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2275.277% |
| BeiGene, Ltd. | 2.23 Billion USD | 77.862% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2222.751% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -88.458% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2224.476% |
| Erasca, Inc. | 78.61 Million USD | -529.058% |
| bluebird bio, Inc. | 424.62 Million USD | -16.458% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -75368.522% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 73.836% |
| DBV Technologies S.A. | 42.8 Million USD | -1055.395% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -75368.522% |
| Moderna, Inc. | 4.57 Billion USD | 89.184% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -6969.464% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -29761.655% |
| Molecular Templates, Inc. | 31.17 Million USD | -1486.439% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2796.948% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 15.915% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -297.18% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1702.344% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1256.454% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -788.845% |
| MacroGenics, Inc. | 154.2 Million USD | -220.679% |
| RenovoRx, Inc. | 4.46 Million USD | -10972.75% |
| Adicet Bio, Inc. | 37.12 Million USD | -1232.19% |
| Prime Medicine, Inc. | 60.78 Million USD | -713.605% |
| Aditxt, Inc. | 28.53 Million USD | -1633.2% |
| Adagene Inc. | 45.16 Million USD | -994.789% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -273561.463% |
| Quantum-Si incorporated | 26.63 Million USD | -1756.892% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 29.109% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -16153.708% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -330.154% |
| SciSparc Ltd. | 1.59 Million USD | -30903.699% |
| Vericel Corporation | 127.7 Million USD | -287.228% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8786.225% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -479.335% |
| Generation Bio Co. | 171.63 Million USD | -188.125% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -4181.463% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1082.159% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -95.692% |
| Invivyd, Inc. | 51.71 Million USD | -856.257% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -437.644% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -7501.69% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -555.014% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -48333.79% |
| 2seventy bio, Inc. | 310.12 Million USD | -59.454% |
| ADMA Biologics, Inc. | 193.97 Million USD | -154.933% |
| Clene Inc. | 38.95 Million USD | -1169.567% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1268.585% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -92.434% |
| GeoVax Labs, Inc. | 3.51 Million USD | -13949.026% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -159.908% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -3960.121% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -149.347% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -3955.081% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -927.85% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -835.843% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -33.704% |
| Evaxion Biotech A/S | 17.61 Million USD | -2706.922% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -207.284% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -222.816% |
| Trevena, Inc. | 48.26 Million USD | -924.634% |
| Surrozen, Inc. | 8.14 Million USD | -5971.32% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2189.924% |
| Cingulate Inc. | 10.36 Million USD | -4672.854% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -17882.145% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1226.046% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -13687.989% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -3660.525% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -55.898% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1890.056% |
| Clearmind Medicine Inc. | 3.61 Million USD | -13598.28% |
| Kronos Bio, Inc. | 54.2 Million USD | -812.361% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -951.185% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2072.736% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2363.799% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2080.716% |
| ImmunityBio, Inc. | 1.09 Billion USD | 54.648% |
| Korro Bio, Inc. | 51.75 Million USD | -855.536% |
| Kineta, Inc. | 7.22 Million USD | -6747.258% |
| BioVie Inc. | 9.7 Million USD | -4996.912% |
| Codexis, Inc. | 49.94 Million USD | -890.087% |
| Celularity Inc. | 102.92 Million USD | -380.437% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -413.792% |
| Celcuity Inc. | 51.45 Million USD | -861.143% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -143155.387% |
| Cibus, Inc. | 206.11 Million USD | -139.917% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1064.235% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1777.478% |
| IN8bio, Inc. | 8.77 Million USD | -5537.358% |
| Kodiak Sciences Inc. | 213.59 Million USD | -131.521% |
| Annexon, Inc. | 47.11 Million USD | -949.512% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -452.271% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -413.125% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -3512.455% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 81.005% |
| Eyenovia, Inc. | 19.78 Million USD | -2400.01% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -179.248% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -6338.081% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1951.99% |
| Arcellx, Inc. | 339.75 Million USD | -45.55% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -4056.236% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -101.397% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -5071.066% |
| Moolec Science SA | 13.94 Million USD | -3446.048% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1045.97% |
| Geron Corporation | 146.12 Million USD | -238.41% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -878.606% |
| Royalty Pharma plc | 6.29 Billion USD | 92.148% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1143.235% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -167868.384% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -19999.688% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -161.429% |
| Humacyte, Inc. | 114.67 Million USD | -331.219% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1602.21% |
| 89bio, Inc. | 59.96 Million USD | -724.69% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1768.681% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -41246.906% |
| Genelux Corporation | 8.42 Million USD | -5773.029% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -7112.792% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -262.759% |
| Notable Labs, Ltd. | 4.42 Million USD | -11070.296% |
| Liquidia Corporation | 73.13 Million USD | -576.131% |
| Mustang Bio, Inc. | 17.61 Million USD | -2706.68% |
| Immunovant, Inc. | 48.95 Million USD | -910.13% |
| Quantum-Si incorporated | 26.63 Million USD | -1756.892% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1188.354% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -15836.481% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -569.513% |
| Acasti Pharma Inc. | 11.55 Million USD | -4178.87% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2087.345% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -18091.138% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1240.969% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -36185.131% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -8012.024% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1891.178% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2032.975% |
| PepGen Inc. | 34.63 Million USD | -1327.937% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3972.044% |
| United Therapeutics Corporation | 1.18 Billion USD | 58.17% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -6980.599% |
| Solid Biosciences Inc. | 38.45 Million USD | -1185.842% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5678.869% |
| Immuneering Corporation | 12 Million USD | -4018.041% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -157458.195% |
| Silo Pharma, Inc. | 1.56 Million USD | -31412.041% |
| Belite Bio, Inc | 4.21 Million USD | -11643.268% |
| XOMA Corporation | 145.58 Million USD | -239.682% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -20266.928% |
| Bionomics Limited | 10.15 Million USD | -4767.827% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2201.005% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2058.203% |
| uniQure N.V. | 624.01 Million USD | 20.754% |
| Cassava Sciences, Inc. | 14.19 Million USD | -3383.684% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -273561.463% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -190.573% |
| Forte Biosciences, Inc. | 3.66 Million USD | -13389.062% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -189670.246% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -7229.317% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -6338.081% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2744.785% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -4579.305% |
| Altimmune, Inc. | 16.54 Million USD | -2889.596% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 19.944% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2058.203% |
| Compugen Ltd. | 55.77 Million USD | -786.614% |
| Peak Bio, Inc. | 20.75 Million USD | -2282.79% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -347.669% |
| Benitec Biopharma Inc. | 4.96 Million USD | -9865.921% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -213.292% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -557.819% |
| Zura Bio Limited | 21.29 Million USD | -2222.511% |
| PolyPid Ltd. | 17.46 Million USD | -2730.942% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -339.959% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -557.819% |
| Instil Bio, Inc. | 99.8 Million USD | -395.495% |
| argenx SE | 444.95 Million USD | -11.138% |
| Immunome, Inc. | 28.65 Million USD | -1625.553% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -5831.498% |
| Verona Pharma plc | 58.84 Million USD | -740.416% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3316.769% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3228.01% |
| CervoMed Inc. | 2.59 Million USD | -18950.74% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -10045.856% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3782.765% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -4593.963% |
| Moolec Science SA | 13.94 Million USD | -3446.048% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -21001.265% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -789.48% |
| AnaptysBio, Inc. | 364.28 Million USD | -35.747% |
| Design Therapeutics, Inc. | 11.95 Million USD | -4036.074% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3798.683% |
| NeurAxis, Inc. | 1.91 Million USD | -25753.449% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1170.317% |
| Lumos Pharma, Inc. | 13.33 Million USD | -3608.91% |
| Achilles Therapeutics plc | 19.08 Million USD | -2490.816% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3316.769% |
| 180 Life Sciences Corp. | 5.38 Million USD | -9079.317% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1996.444% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2072.736% |
| Nutriband Inc. | 1.07 Million USD | -45733.747% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1516.148% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3307.822% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -23.235% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1422.831% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -3689.604% |
| Palisade Bio, Inc. | 2.73 Million USD | -17954.363% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -9313.84% |
| Beam Therapeutics Inc. | 478.38 Million USD | -3.371% |
| Neurogene Inc. | 36.54 Million USD | -1253.003% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -24.264% |
| AEON Biopharma, Inc. | 159.88 Million USD | -209.283% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -937.794% |
| Sesen Bio, Inc. | 30.98 Million USD | -1496.014% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1804.815% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -6404.801% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -152.638% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -157.48% |
| Athira Pharma, Inc. | 30.05 Million USD | -1545.237% |
| Vaccinex, Inc. | 5.94 Million USD | -8222.265% |
| HCW Biologics Inc. | 15.05 Million USD | -3185.35% |
| XOMA Corporation | 145.58 Million USD | -239.682% |
| Nektar Therapeutics | 267.04 Million USD | -85.177% |
| Arvinas, Inc. | 644.6 Million USD | 23.284% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2688.617% |
| Merus N.V. | 102.15 Million USD | -384.096% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -237.895% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -419.879% |
| Rezolute, Inc. | 11.73 Million USD | -4114.326% |
| Clene Inc. | 38.95 Million USD | -1169.567% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -17267.159% |
| BeyondSpring Inc. | 48.26 Million USD | -924.486% |
| Synlogic, Inc. | 32.89 Million USD | -1403.295% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3284.035% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -30163.709% |
| Peak Bio, Inc. | 20.75 Million USD | -2282.79% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -679.257% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1145.176% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -31.293% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -396.65% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -114177.626% |
| MannKind Corporation | 721.36 Million USD | 31.448% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2114.054% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -23606.088% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -382.025% |
| Gossamer Bio, Inc. | 249.14 Million USD | -98.481% |
| CohBar, Inc. | 1.03 Million USD | -47741.604% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -4526.335% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2496.12% |
| Legend Biotech Corporation | 589.93 Million USD | 16.175% |
| Mural Oncology plc | 37.92 Million USD | -1203.81% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -272.832% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -21444.116% |
| Disc Medicine, Inc. | 22.87 Million USD | -2061.788% |
| Champions Oncology, Inc. | 28.03 Million USD | -1663.899% |
| REGENXBIO Inc. | 262.22 Million USD | -88.58% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -14620.369% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3845.341% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -3581.676% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2232.04% |
| Vaxart, Inc. | 34.02 Million USD | -1353.37% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2325.34% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1633.181% |
| Cellectis S.A. | 249.57 Million USD | -98.14% |
| Longeveron Inc. | 5.33 Million USD | -9165.674% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1082.498% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 79.44% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -719.158% |
| Revolution Medicines, Inc. | 262.39 Million USD | -88.458% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -23369.815% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -5632.773% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -4090.399% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -3421.391% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -22889.726% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 90.398% |
| Denali Therapeutics Inc. | 122.96 Million USD | -302.161% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8786.225% |
| Veru Inc. | 32.81 Million USD | -1407.066% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -7099.141% |
| Cingulate Inc. | 10.36 Million USD | -4672.854% |
| Passage Bio, Inc. | 39.26 Million USD | -1159.51% |
| Context Therapeutics Inc. | 4.19 Million USD | -11697.295% |
| Exicure, Inc. | 8.54 Million USD | -5684.408% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1575.847% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -4615.897% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2143.587% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -203.406% |
| Nuvalent, Inc. | 31.82 Million USD | -1453.936% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -7673.31% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -684.661% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2647.272% |
| OmniAb, Inc. | 87.4 Million USD | -465.8% |
| Anew Medical, Inc. | 8.24 Million USD | -5900.013% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1191.514% |
| Lipocine Inc. | 2.63 Million USD | -18690.985% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1782.266% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1129.755% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1756.139% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -473.983% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -9055.879% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -497.616% |
| Ocugen, Inc. | 23.98 Million USD | -1961.915% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -965.591% |
| Q32 Bio Inc. | 233.12 Million USD | -112.119% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -5354.544% |
| Alumis Inc. Common Stock | 53.5 Million USD | -824.281% |
| Equillium, Inc. | 27.95 Million USD | -1668.82% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -139.365% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -8688.67% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -7963.127% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -214.321% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -612.21% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -4857.881% |
| Dominari Holdings Inc. | 4.63 Million USD | -10569.018% |
| Edesa Biotech, Inc. | 1.84 Million USD | -26751.6% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1572.503% |
| Bio-Techne Corporation | 744.34 Million USD | 33.564% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -292.159% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -43.562% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1118.753% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1607.736% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -435.415% |
| Nkarta, Inc. | 105.6 Million USD | -368.285% |
| BioCardia, Inc. | 4.59 Million USD | -10673.617% |
| Iterum Therapeutics plc | 32.66 Million USD | -1414.019% |